U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP
  1. Approved Blood Products

SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP

STN: BL 125608
Proper Name: Sodium Citrate 4% W/V Anticoagulant Solution USP
Tradename: N/A
Manufacturer: Terumo BCT, Inc.
Indication:

  • Intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures.

Product Information

Supporting Documents

Back to Top